EDSA
Edesa Biotech, Inc.
+0.25 (+6.42%)4.12USD12.7K成交股數39.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 9 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.0M | 2.8M | 1.1M | 939K | 484K | 1.0M | 104K | 897K | 1.2M | 704K | 1.0M | 1.5M |
| 銷售管理費用 | 1.6M | 1.5M | 1.2M | 965K | 1.2M | 879K | 901K | 1.0M | 1.0M | 1.2M | 1.0M | 952K |
| 營業利益 | −5.5M+237% | −4.3M+126% | −2.3M+133% | −1.9M-1% | −1.6M-26% | −1.9M+2% | −1.0M-51% | −1.9M-20% | −2.2M | −1.9M | −2.1M | −2.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −5.4M+240% | −4.2M+161% | −2.2M+134% | −1.7M+5% | −1.6M-15% | −1.6M-4% | −962K-52% | −1.7M-29% | −1.9M | −1.7M | −2.0M | −2.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 10.3M | 10.0M | 12.1M | 12.4M | 13.9M | 1.6M | 1.0M | 2.0M | 2.8M | 4.3M | 6.5M | 7.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 12.7M | 12.4M | 14.7M | 14.8M | 16.5M | 4.2M | 3.8M | 5.2M | 6.5M | 7.8M | 9.4M | 10.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | – | – | – | 1.8M | 2.4M | 2.2M | 2.0M | 1.6M | 1.7M |
| 股東權益 | 8.8M | 10.2M | 14.0M | 14.1M | 15.5M | 2.3M | 2.0M | 2.9M | 4.3M | 5.8M | 7.9M | 9.0M |
| 負債比 | – | – | – | – | – | – | 48.1% | 45.2% | 33.2% | 25.4% | 16.7% | 15.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −2.1M | – | – | −1.5M+8% | – | – | – | −1.4M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | 25K | – | – | 43K | – | – | – | 45K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2018 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2018 年度 · 212K
| 產品 | 212K | 100.0% | +18.8% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −7.2M | –% | – | – |
| FY2024 | – | – | −6.2M | –% | – | – |
| FY2023 | – | – | −8.4M | –% | – | −6.6M |
| FY2022 | – | – | −17.5M | –% | – | −12.3M |
| FY2021 | 0.00 | -100.0% | −13.3M | –% | -1.10 | −13.7M |
| FY2020 | 329K | – | −6.4M | -1,935.3% | -0.74 | −5.0M |
| FY2019 | 0.00 | -100.0% | −1.5M | –% | -0.47 | −1.3M |
| FY2018 | 212K | – | −5.0M | -2,378.6% | -1.76 | −5.0M |